Risk factors | Liver Metastasis | P* | ||
---|---|---|---|---|
 | n | Negative | Positive |  |
Gender | Â | Â | Â | Â |
Male | 247 | 182 | 65 | 0.939 |
Female | 108 | 80 | 28 | Â |
Age | Â | Â | Â | Â |
≤ 55 | 54 | 22 | 32 | < 0.001 |
> 55 | 301 | 240 | 61 | Â |
Tumour localization | Â | Â | Â | Â |
Rectum | 203 | 150 | 53 | 0.965 |
Colon | 152 | 112 | 40 | Â |
Tumour size (cm) | Â | Â | Â | Â |
≤ 5 | 120 | 102 | 18 | 0.001 |
> 5 | 235 | 160 | 75 | Â |
Type of tumour | Â | Â | Â | Â |
Adenocarcinoma | 299 | 232 | 67 | 0.002 |
Mucinous adenocarcinoma | 31 | 17 | 14 | Â |
Signet-ring cell carcinoma | 16 | 9 | 7 | Â |
Undifferentiated carcinoma | 9 | 4 | 5 | Â |
Tumour cell differentiation | Â | Â | Â | Â |
Well/moderately differentiated | 279 | 236 | 43 | < 0.001 |
Poorly differentiated | 76 | 26 | 50 | Â |
Tumour invasion depth | Â | Â | Â | Â |
T1 | 5 | 5 | 0 | 0.002 |
T2 | 63 | 20 | 1 | Â |
T3 | 252 | 221 | 72 | Â |
T4 | 35 | 25 | 20 | Â |
Lymph node metastasis | Â | Â | Â | Â |
< 4 | 123 | 104 | 19 | 0.001 |
≥ 4 | 232 | 158 | 74 |  |
Nuclear beta-catenin expression in SLN(s) | ||||
≤ 50% | 254 | 231 | 23 | < 0.001 |
> 50% | 101 | 31 | 70 | Â |